Azziz, Ricardo <br/><br/>
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome.  [electronic resource] 

 -  Fertility and sterility  Apr 2003 
 - 932-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0015-0282 
<br/><br/><label>Standard No.: </label>10.1016/s0015-0282(02)04914-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Glands--drug effects<br/>Adult<br/>Blood Glucose--metabolism<br/>Chromans--pharmacology<br/>Dehydroepiandrosterone Sulfate--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Glucose Tolerance Test<br/>Humans<br/>Hyperandrogenism--blood<br/>Hyperinsulinism--blood<br/>Hypoglycemic Agents--pharmacology<br/>Insulin--blood<br/>Insulin Resistance--physiology<br/>Polycystic Ovary Syndrome--blood<br/>Prospective Studies<br/>Thiazoles--pharmacology<br/>Thiazolidinediones<br/>Troglitazone